FULGENT GENETICS, INC. Payments of Capital Distribution
FULGENT GENETICS, INC. (FLGT) reported Payments of Capital Distribution of $4.59 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfCapitalDistribution · last filed 2018-03-20
- FULGENT GENETICS, INC. payments of capital distribution for the quarter ending 2016-12-31 was $0.00.
- FULGENT GENETICS, INC. payments of capital distribution for fiscal 2016 was $4.59M.
| Period end | Payments of Capital Distribution 3 month | Payments of Capital Distribution 9 month | Payments of Capital Distribution 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $4.59M 10-K · filed 2018-03-20 | |
| 2016-09-30 | $4.59M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |